Chromogranin-A expression in neoplastic neuroendocrine cells and prognosis in colorectal cancer

Tumori

Volumn 82, Issue 4, 1996, Pages 390-393

  Secco, Giovanni Battista ^a   Campora, Elisabetta ^a   Fardelli, Roberto ^a   Lapertosa, Gabriella ^b   De Lucchi, Francesca ^b   Gianquinto, Daniela ^a   Bonfante, Pierfrancesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

chromogranin; colorectal adenocarcinoma; immunohistochemical methods; prognostic fators

Indexed keywords

CHROMOGRANIN A;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROSECRETORY CELL; PROGNOSIS;

EID: 0029850660     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200419     Document Type: Article

References (26)

1. Arends J.W., Wiggers T., Verstijnen K., Bosman F.T.: The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma. J. Pathol., 149: 97-102, 1986.
2. Bonar S.F., Sweeney E.C.: The prevalence, prognostic significance and hormonal content of endocrine cells in gastric cancer. Histopathology, 10: 53-63, 1986.
3. Broders A.C.: Carcinoma grading and practical application. Arch. Pathol. Lab. Med., 2: 376-381, 1986.
4. Cox W.F., Pierce G.B.: The endodermal origin of the endocrine cells of an adenocarcinoma of the colon of the rat. Cancer, 50: 1530-1538, 1992.
5. De Lellis R.A., Stemberg L.A., Mann R.B., Banks P.M., Nakane P.K.: Immunoperoxidase technics in diagnostic pathology. Am. J. Clin. Pathol., 71: 483-488, 1979.
6. Facer P., Bishop A.E., Lloyd R.V., Wilson B.S., Hennessy R.J., Polak J.M.: Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract. Gastroenterology, 89: 1366-1373, 1985.
7. Facer P., Bishop A.E., Cole G.A., Aitchison M., Kendall C.H., Van Aswegen G., Penketh R.J.A., Rodek C.H., McKeever P., Polakjm J.A.: Developmental profile of chromogranin, hormonal peptide and 5-hydroxytryptamine in gastrointestinal endocrine cells. Gastroenterology, 97: 48-57, 1989.
8. Ferrero S., Buffa R., Pruneri G., Siccardi A.G., Pelagi M., Lee A.K.C., Coggi G., Bosari S.: The prevalence and clinical significance of chromogranin-A and secretogranin II immunoreactivity in colorectal adenocarcinomas. Virchows Arch., 426: 587-592, 1995.
9. Gaffey M.J., Mills S.E., Lack E.E.: Neuroendocrine carcinoma of the colon and rectum. A clinico-pathologic, ultrastructural and immunohistochemical study of 24 cases. Am. J. Surg. Pathol., 14: 1010-1023, 1990.
10. Hamada Y., Oishi A., Shoji T., Takada H., Yamamura Hioki K., Yamamoto M.: Endocrine cells and prognosis in patients with colorectal carcinoma. Cancer, 69: 2641-2646, 1992.
11. Helman L.J., Gazdar A.F., Park J.G., Cohen P.S., Cotelingan J.D., Israel M.A.: Chromogranin expression in normal and malignant human tissues. J. Clinic Invest., 82: 686-690, 1988.
12. Hermanek P., Sobin L.H. (Eds.): TNM classification of malignant tumours, 4th edn., 2nd Revision, Springer-Verlag, Berlin, 1992.
13. Hsu S.M., Raine L.: The use of avidin-biotin-peroxidase complex in diagnostic and research pathology. In: Advances in immunohistochemistry, De Lellis R.A. (Ed.), pp. 31-34, Masson, New York, 1984.
14. Iwashita A.: Argyrophil and argentaffin cells in carcinoma of colon and rectum. Fukuoka Acta Med., 70: 370-390, 1979.
15. Jass J.R., Aktin W.S., Cuzick J., Bussey H.J.R., Morson B.C., Northover J.M.A., Todd J.P.: The grading of rectal cancer: histological perspectives and a multivariate analysis of 447 cases. Histopathology, 10: 437-459, 1986.
16. Kubo T., Watanabe H.: Neoplastic argentaffin cells in gastric and intestinal carcinomas. Cancer, 27: 447-454, 1971.
17. Lloyd R.V., Cano M., Rosa P., Hille A., Huttner W.B.: Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumours. Am. J. Pathol., 130: 296-304, 1988.
18. Mori M., Mimori K., Kamakura T., Iked Y., Sugimachi K.: Chromogranin positive cells in colorectal carcinoma and transitional mucosa. J. Clin. Pathol., 48: 754-758, 1995.
19. Park J.G., Choe G.Y., Helman L.J., Gazdar A.F., Yang H.K., Kim J.P., Park S.H., Kim Y.I.: Chromogranin-A expression in gastric and colon cancer tissues. Int. J. Cancer, 51: 189-194, 1992.
20. Perez A.M., Saul S.H., Trojanowsky J.Q.: Neurofilament and chromogranin expression in normal and neoplastic neuroendocrine cells of the human gastrointestinal tract and pancreas. Cancer, 62: 1219-1227, 1990.
21. Secco G.B., Fardelli R., Campora E., Rovida S., Martinoli C., Motta G.: Results of postoperative follow-up vs non follow-up in colorectal cancer. Coloproctology, 6: 362-368, 1990.
22. Secco G.B., Fardeili R., Campora E., Lapertosa G., Fulcheri E., Rovida S., Motta G.: Prognostic value of the Jass histopathologic classification in left colon and rectal cancer. Digestion, 47: 71-80, 1990.
23. Sidhu G.S.: The endodermal origin of digestive and respiratory tract APUD cells. Histopathologic evidence and a review of the literature. Am. J. Pathol. 96: 5-20, 1979.
24. Smith D.M., Haggitt R.C.: The prevalence and prognostic significance of argyrophil cells in colorectal carcinomas. J. Surg. Pathol., 8: 123-128, 1984.
25. Ulich T.R., Cheng L., Glover H., Yang K., Lewin K.S.: A colonic adenocarcinoma with argentaffin cells. An immunoperoxidase study demonstrating the presence of numerous neuroendocrine products. Cancer, 51: 1483-1489, 1983.
26. Wiedenmann B., Waldherr R., Buhr H., Hille A., Rosa P., Huttner N.B.: Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin, secretogranin I (chromogranin B) and secretonin H. Gastroenterology, 95: 1364-1374, 1988.